FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,276 letters match. Newest first.
-
DrugsIntas Pharmaceuticals Limited
FDA cited Intas Pharmaceuticals for CGMP violations, including manipulated visual inspection records and inadequate sterile-drug controls.
High risk -
DrugsAmLion Toothpaste Mfg. Sdn. Bhd.
FDA cites AmLion Toothpaste in Malaysia for CGMP failures, including no testing of glycerin and sorbitol for DEG/EG; firm stays on import alert.
High risk -
DrugsCipla Limited
FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.
High risk -
DrugsDiscover Health, LLC d/b/a Discover CBD and Strain Snobs
FDA warns Discover Health over unapproved CBD, CBG, HHC, and Delta-8 THC drugs, unsafe CBD/Delta-8 foods, and unapproved animal drugs.
High risk -
DrugsCerci Kozmetik Ve Otel Ekipmanlari Pazarlama Ic Ve Dis Ticaret Limited Sirketi
FDA: Turkish OTC drug maker Cerci shipped to the U.S. without finished-product identity and strength testing.
High risk -
DrugsXiamen Wally Bath Manufacture Co., Ltd.
FDA warns Xiamen Wally Bath over current good manufacturing practice failures for over-the-counter hand sanitizer, including raw material and release testing gaps.
High risk -
DrugsMelanie M. Hoppers, M.D./Physicians Quality Care
FDA warns Dr. Melanie Hoppers over enrolling ineligible patients in a baloxavir marboxil influenza trial.
High risk -
DrugsNational Chemical Laboratories
National Chemical Laboratories’ OTC topical drugs were adulterated after FDA found manufacturing quality violations, including untested BZK and weak quality oversight.
High risk -
Drugswww.directpharmashop.net
FDA warned DirectPharmaShop.net over selling unapproved, misbranded antipsychotics to U.S. consumers online.
High risk -
DrugsBrenntag Great Lakes, LLC
Brenntag Great Lakes failed to prevent cross-contamination of OTC hand sanitizer made on equipment shared with industrial chemicals.
High risk -
DrugsElemental Herbs Inc. d/b/a ALL good
Elemental Herbs (ALL good) cited for CGMP failures and unapproved, misbranded Goop Skin Recovery Balm.
High risk -
DrugsAmazon.com, Inc.
FDA warned Amazon for selling seven unapproved eye drug products on Amazon.com.
High risk -
DrugsSaruhan Kimya Ve Temizlik Urunleri Sanayi Ticaret Anonim Sirketi Corlu Subesi
FDA found manufacturing violations at Turkish OTC drug maker, including missing identity, release, and stability testing for hand sanitizers.
High risk -
DrugsGlobal Pharma Healthcare Private Limited
FDA warned Global Pharma Healthcare that non-sterile artificial tears and eye ointment from its India plant were tied to a Pseudomonas outbreak with four deaths.
High risk -
DrugsDexterity Health, LLC DBA Zazzee Naturals
Zazzee Naturals sells Liquid MSM eye drops online as an unapproved new drug, FDA says in warning letter.
High risk -
DrugsSamm Solutions, Inc., d.b.a. BTS Research
Samm Solutions/BTS Research failed good laboratory practice (GLP) rules for nonclinical drug studies, FDA says.
Medium -
DrugsMaria W. Greenwald, M.D.
FDA warned Dr. Maria W. Greenwald over clinical trial violations involving investigational drugs, including ineligible subjects and inaccurate records.
High risk -
DrugsALI Pharmaceutical Manufacturing, LLC
FDA says ALI Pharmaceutical Manufacturing failed to validate and control its porcine thyroid drug substance process, making the drug substance adulterated.
High risk -
DrugsHandock Cosmetics Co., Ltd.
FDA warns Handock Cosmetics over manufacturing quality failures and unapproved/mislabeled hand sanitizers from South Korea.
High risk -
DrugsHygienic Labs, LLC
Hygienic Labs, an OTC drug manufacturer, failed to respond to FDA records requests.
Medium -
DrugsSun Pharmaceutical Industries Ltd.
FDA warns Sun Pharmaceutical over CGMP violations in sterile injectable manufacturing at its Halol, India facility.
High risk -
Drugswww.semaspace.com
FDA warned semaspace.com for selling unapproved, misbranded injectable semaglutide drugs online without prescriptions.
High risk -
Drugswww.gorillahealing.com
FDA warned gorillahealing.com for selling unapproved, misbranded semaglutide and tirzepatide drugs to U.S. consumers online.
High risk -
DrugsSeoul Cosmetics Co., Ltd.
FDA warned Seoul Cosmetics, a South Korean drug maker, over poor manufacturing quality and unapproved OTC drugs.
High risk -
Drugswww.alphamedstore.com
FDA warned www.alphamedstore.com that it sells unapproved, illegally labeled opioid drugs, including Zomorph morphine capsules, to U.S. consumers.
High risk -
DrugsAntonio E. Blanco, M.D./Vista Health Research, LLC
FDA cited Dr. Antonio E. Blanco/Vista Health Research for enrolling ineligible trial subjects and missing required safety imaging.
High risk -
DrugsShot of Joy LLC
FDA warned Shot of Joy LLC that its kratom and kava products are unapproved new drugs marketed for opioid addiction and other conditions.
High risk -
DrugsLuis Javier Pena-Hernandez, M.D., FCCP
FDA warns Dr. Pena-Hernandez over ineligible subject enrollment and lapsed IRB approval for investigational drugs.
High risk -
DrugsSouthern Tier Home Infusion, Inc. dba Pharmacy Innovations
FDA warned compounding pharmacy Pharmacy Innovations that its sterile drugs were made under insanitary conditions and without valid patient prescriptions.
High risk -
DrugsZhao Qing Longda Biotechnology Co. Ltd.
FDA says Zhao Qing Longda Biotechnology refused records access for OTC drugs, including children’s toothpaste, and placed its drugs on import alert.
High risk -
DrugsGulf States International, Inc.
Gulf States International refused FDA requests for OTC drug manufacturing records, FDA says.
Medium -
DrugsMaison Blanche LLC
FDA warns Maison Blanche for refusing repeated requests for records on its OTC hand sanitizer.
Medium -
DrugsWalgreen Company
FDA warns Walgreen Company that its Walgreens Sensitive Extra Whitening drug listing is incomplete and inaccurate.
Low -
DrugsKor-Chem, Inc.
Kor-Chem, Inc. made OTC hand sanitizer drugs with manufacturing violations, including shared equipment with industrial chemicals and missing identity and microbial testing.
High risk -
DrugsPureChemPros LLC
FDA warns PureChemPros over manufacturing quality failures and unapproved, misbranded hand sanitizer and hydrogen peroxide drugs.
High risk -
DrugsBoiron, Inc.
FDA warns Boiron that Optique 1 Eye Drops are an unapproved new drug sold with drug claims.
High risk -
DrugsNatural Ophthalmics, Inc.
FDA warned Natural Ophthalmics that six eye drop products are unapproved new drugs sold without FDA approval.
High risk -
DrugsDR Vitamins, LLC dba DR Vitamin Solutions
FDA warned DR Vitamin Solutions that its eye drops are unapproved new drugs and misbranded.
High risk -
DrugsCVS Health
FDA told CVS Health its unapproved Pink Eye Relief Drops are an illegal new drug made by a manufacturer with serious quality violations.
High risk -
DrugsTRP Company, Inc
FDA warns TRP Company that its homeopathic eye drops and ointments are unapproved new drugs and may be adulterated.
High risk -
DrugsOcluMed LLC
OcluMed sells unapproved eye drops with website claims to treat or prevent cataracts, FDA says.
High risk -
DrugsWalgreens Boots Alliance, Inc.
FDA warned Walgreens over three store-brand eye drops sold as unapproved new drugs and tied to contract manufacturer manufacturing violations.
High risk -
DrugsSimilasan AG
Similasan AG's ophthalmic drugs are unapproved new drugs and violate CGMP (manufacturing quality rules), FDA says.
High risk -
DrugsSafecor Health, LLC
FDA warned drug repackager Safecor Health over CGMP failures that let tablets from other drugs contaminate packaging lines.
High risk -
DrugsGreen Pharmaceutical Co. Ltd.
FDA warns South Korea's Green Pharmaceutical over OTC drug CGMP failures, including missing identity testing and weak quality unit.
High risk -
DrugsLex Inc.
FDA warns Lex Inc. of Medley, Florida, that its over-the-counter drugs are adulterated because manufacturing rules were not met, including missing toxic-ingredient testing.
High risk -
DrugsGadal Laboratories Inc.
FDA warned Gadal Laboratories of CGMP violations at its Miami drug plant, including unqualified suppliers and contamination risks in pediatric OTC drugs.
High risk -
DrugsCosmobeauti Laboratories & Manufacturing Inc.
FDA warns Cosmobeauti Laboratories over manufacturing rule violations for OTC sunscreen drugs, including backdated batch records and missing microbial testing.
High risk -
DrugsK.C. Pharmaceuticals Inc.
FDA warned K.C. Pharmaceuticals after inspections found manufacturing rule violations in sterile ophthalmic drugs, including inadequate contamination controls and cleaning validation.
High risk -
DrugsMolluscumaway LLC
FDA warned Molluscumaway LLC that its molluscum patches, ointment, and body wash are unapproved new drugs.
High risk